Ubiquitin-dependent proteolysis of the mitotic cyclins A and B is required for the completion of mitosis and entry into the next cell cycle. This process is catalyzed by the cyclosome, an -22S particle that contains a cyclinselective ubiquitin ligase activity, E3-C, that requires a cyclinselective ubiquitin carrier protein (UBC) E2-C. Here we report the purification and cloning of E2-C from clam oocytes.
report the purification and cloning of E2-C from clam oocytes.
The deduced amino acid sequence of E2-C indicates that it is a new UBC family member. Bacterially expressed recombinant E2-C is active in in vitro cyclin ubiquitination assays, where it exhibits the same substrate specificities seen with native E2-C. These results demonstrate that E2-C is not a homolog ofUBC4 or UBC9, proteins previously suggested to be involved in cyclin ubiquitination, but is a new UBC family member with unique properties.
Mitotic entry and exit in most organisms is controlled by the synthesis and destruction of cyclin B, a positive regulatory subunit of the protein kinase cdc2, the catalytic component of mitosis-promoting factor (1, 2) . Cyclins are marked for destruction by the covalent addition of ubiquitin at the end of mitosis (3) (4) (5) . Ubiquitinated cyclins are then rapidly degraded by the 26S proteasome (5) . Previous work with cell-free systems derived from clam eggs led to the discovery that this process is catalyzed by a cyclin-specific ubiquitin ligase, E3-C, which is part of an -22S particle, the cyclosome (6) . Cyclosome activation is initiated by cdc2 (6, 7) and terminated by an okadaic acid-sensitive phosphatase (8) . Subsequent work with other organisms has revealed that this particle contains homologs of two yeast proteins, cdc16 and cdc27 (9) , proteins required for the destruction of cyclin B and the metaphaseanaphase transition (10, 11) . Cyclosome-associated E3-C catalyzes cyclin ubiquitination using a specialized E2 (ubiquitin carrier protein; also called ubiquitin-conjugating enzyme or UBC) originally identified in clams as E2-C (5) .
Multiple species of E2s were first found in animal cells (12) and at least 10 different UBCs have now been identified in yeast (13) . While all of these are related structurally, genetic and molecular analysis has revealed that different UBCs have different cellular functions. Two closely related UBCs, UBC4 and UBC5, appear responsible for ubiquitin-dependent degradation of most short-lived and abnormal proteins (13). UBC2 (RAD6) is required for several functions, including DNA repair, sporulation (14) , and N-end rule degradation (15) . UBC3 (CDC34) is required for the G1/S transition (16) ,
where it appears to participate in the ubiquitin-dependent destruction of the G1 cdk inhibitor, p40sicl (17) . UBC9 is required for cell cycle progression in late G2 or early M; both CLB5, an S-phase cyclin, and CLB2, an M-phase cyclin, are stable in UBC9 mutants, suggesting that UBC9 may be re-
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sponsible for cyclin ubiquitination (18) . In extracts of frog eggs, recombinant UBC4 protein, as well as an unidentified E2 species, can ubiquitinate cyclins (9) . Furthermore (19) . El was purified from human erythrocytes by affinity chromatography on Ub-Sepharose (20) . Sea urchin cyclin B (13-91)/protein Awas expressed and purified as described (3) .
Proteins were radioiodinated by the chloramine T procedure. Recombinant UBCH5 (21) was generously provided by A. Ciechanover (Technion, Haifa, Israel).
Purification of E2-C. Extracts of M-phase clam oocytes were prepared and fractionated on DEAE-cellulose, as described (5) . Fraction 1 (flowthrough) was centrifuged at 100,000 x g for 1 hr. The supernatant, previously shown to contain E2C (5), was used for purification of this protein. Fraction 1A, a subfraction containing active E3-C, was prepared by salt extraction and ammonium sulfate fractionation, as described (6) . E2-C was first subjected to cation-exchange chromatography on Mono S. This was required to separate it from at least some of the many other E2 species present in this fraction (5) and from ubiquitin, which would interfere with the subsequent step of affinity chromatography on ubiquitin-Sepharose. Free ubiquitin does not bind to this column, whereas E2-C does. A sample of the high-speed supernatant of fraction 1 (5) (10 mg of protein) was applied to a Mono S HR 5/5 column (Pharmacia) equilibrated with 20 mM Hepes-KOH (pH 7.2) containing 1 mM dithiothreitol (DTT) (buffer A). The column was washed with 10 ml of buffer A and then subjected to a 40-ml gradient of 0-200 mM KCI in buffer A. Samples of 1 ml were collected at a flow rate of 1 ml/min into tubes containing 0.5 mg of carrier ovalbumin. Fractions were concentrated by centrifuge ultrafiltration with Centricon-10 concentrators (Amicon), and salt was removed with a 1:20 dilution with buffer A, followed by another ultrafiltration to a final vol of 100 ,ul. E2-C eluted at -70 mM KCI. It was incompletely separated from E2-A, an abundant low molecular weight E2 (5) .
For covalent affinity purification, ubiquitin-Sepharose beads ("20 mg of ubiquitin per ml of swollen gel) were prepared as described (20 Fig. 3A .
Production of Recombinant E2-C Protein. PCR product containing the 1.5-kb E2-C insert was diluted 1:1000 and a second PCR was performed with primers CE2Ful (5'-GGGCATATGTCGGGACAAAATATAGATC-3', sense direction) and CE2Rev (5'-GGGAAGCTTCTATTTAT-CACTCTGAGCAG-3', antisense direction), designed to create a 5' Nde I site at the presumptive initiator methionine and a HindIII site at the 3' end; the resulting product was subcloned into pT7-7 (24). The resulting construct was transformed into BL-21(DE3)pLysS cells (Novagen). Cells were grown in 100 ml of LB containing 50 tag of ampicillin per ml and 34 ,jg of chloramphenicol per ml to an OD of 0.6. Isopropyl P-Dthiogalactopyranoside was added to 1 mM, and cells were incubated at 37°C for 3 hr. Cell pellets were washed in cold PBS (140 mM NaCl/2.7 mM KCl/10 mM Na2HPO4/1.8 mM KH2PO4) and lysed in 3 ml of 1 mM EDTA/1 mM DTT/50 mM Tris-HCl, pH 7.6/10 ,/g of leupeptin per ml/10 Ag of chymostatin per ml.
RESULTS
Purification of E2-C for Microsequencing. E2-C was partially purified by cation exchange chromatography on Mono S and then subjected to covalent affinity chromatography on ubiquitin-Sepharose. In the presence of El and MgATP, E2s bind to immobilized ubiquitin by thiolester linkage; ubiquitinbound enzymes can then be eluted with high concentrations of DTT or by raising the pH (20) . In the experiment shown in Fig.  1 , ubiquitin-Sepharose beads were mixed with three kinds of mixtures. The complete mixture contained the peak of E2-C from the Mono S column, El purified from human erythrocytes and MgATP; the two others were controls, lacking either El or the source of E2-C. The fraction not adsorbed to ubiquitin-Sepharose (flowthrough) was collected and, following extensive washing of the beads, the enzymes bound to ubiquitin-Sepharose were eluted with pH 9 buffer containing 5 mM DTT. Quantitative assays of E2-C activity in these fractions ( Fig. 1) showed that, in the complete mixture, virtually all E2-C activity was adsorbed to ubiquitin-Sepharose (removed from the flowthrough) and was recovered in the pH 9 The protein composition of the pH 9 eluates of these treatments was examined by SDS/PAGE and silver staining. As shown in Fig. 1 (1996) several bands in the range of 45-105 kDa that are cleavage products of El (25) 2 and 3) .
It should be noted that the expected molecular sizes of the adducts of E2-C and E2-A with ubiquitin (8.5 kDa) are 29.5 and 24.5, respectively; these are higher than those observed for their putative thiolesters (27 and 18 kDa; see ref. 5 ). This might be due to the well-known anomalous migration of proteins under the partially denaturing electrophoretic conditions required for detection of ubiquitin-E2 thiolesters (26, 27) . To examine further the identity of putative E2-C, the pH 9 eluate of the preparation purified on ubiquitin-Sepharose was subjected to gel filtration on Superose-12. The activity of E2-C (determined by the cyclin-ubiquitin ligation assay) eluted mainly in fractions 33 and 34 ( Fig. 2A) , coincident with the 27-kDa ubiquitin-thiolester band (Fig. 2B) . It was partially separated from the 18-kDa E2-A-ubiquitin thiolester that eluted at a lower size during gel filtration (Fig. 2B) . We conclude that the anomalously migrating 27-kDa adduct is the ubiquitin thiolester of the 21-kDa E2-C protein.
Cloning of Clam E2-C. Based on this identification, the 21-kDa E2-C was chosen for microsequencing. Material originating from 100 ml of clam oocyte extract was processed by the Mono S and ubiquitin-Sepharose steps described above and the 21-kDa band was digested with trypsin as described. Sequences of four tryptic peptides were obtained, as shown in Fig. 3A . A degenerate oligonucleotide primer corresponding to the second peptide was designed, and then with a Agt22 primer to screen a clam ovary cDNA library using PCR, as described. A partial length cDNA clone containing sequences corresponding to three of the four peptides was obtained and used to select several candidate clones encoding full-length E2-C. In these, the first peptide sequence was identified in the N-terminal CATTCTGTCAGCAAAAGGTTACAGCAAGAACTGCGAACTCTCCTTATGTCAGGTGATCCA 180
CCAAAAGACACAGTGTATGAAAGTTTGAAGTATAAGTTAACACTTGAATTCCCCAGTGAC 300
TACCCATACAAACCCCCAGTAGTAAAGTTCACCACACCTTGTTGGCATCCAAATGTTGAT 360
Y P Y K P P V V K F T T P C W H P N V 0 108
CAGTCAGGAAATATATGTCTGGATATATTAAAGGAGAATTGGACTGCTTCCTATGATGTT 420
AAATACAAGACTGCTCAGAGTGATAAATAGATAATACATTTCATACCTAGCTTCAAGTAT 600 (28) . *, Position of the catalytic cysteine residue used for thiolester formation with ubiquitin. region (Fig. 3A) . The same coding sequence was found in other independently isolated cDNA clones.
The sequence obtained contains only one long open reading frame, which is predicted to initiate at the first methionine codon. The size of the presumed translation product is 20 kDa, in good agreement with the size of purified E2-C observed by SDS/PAGE. The encoded protein is clearly an E2, as demonstrated by its extensive alignment with other cloned UBCs and an especially strong homology in the region of the domain containing the catalytic cysteine (Fig. 3B) (Fig. 4) . For comparison, ubiquitin thiolesters of a mixture of natural E2-C and E2-A were separated on the same gel. It may be seen that the recombinant protein formed an adduct with ubiquitin and that the electrophoretic mobility of the ubiquitin thiolester of the recombinant E2 was identical to that of the 27-kDa adduct with native E2-C (Fig. 4, lanes 2 and 3) . In addition, a minor species of a more rapidly migrating ubiquitin adduct of the recombinant protein (labeled *) was observed (lane 3). This may be a cleavage product or an incompletely denatured conformer of an E2-C/ubiquitin thiolester (26, 27) . That both of these adducts are thiolesters is indicated by the observation that they are almost completely abolished by boiling with 2-mercaptoethanol (lanes 4 and 5). A small amount of higher molecular weight derivative persists after boiling with mercaptoethanol (lanes 4 and 5) . This is presumably a product of self-ubiquitination (amide bond formation between ubiquitin and a lysine residue of the E2), previously observed in vitro with some E2s but not with others (29) . It is noteworthy that similar autoubiquitination takes place with both natural and recombinant E2-C.
The ability of the recombinant E2 to promote cyclinubiquitin ligation was tested in the presence of activated, partially purified E3-C-cyclosome complexes. As shown in (9), we also tested the activity of a recombinant human UBC4 homolog, UBCH5 (21) . As shown in Fig. 5A (lane 4 (Fig. 5B, lane 3) . The only stable adduct formed in the presence of the recombinant clam E2-C is a 30-kDa autoubiquitination product. The formation of this product does not require the presence of the nonspecific E3 (data not shown). The amount of the product is higher in Fig. 5 than in Fig. 4 due to the longer incubation time. Its apparent 30-kDa size in the denaturing conditions of gel electrophoresis is close to that expected for recombinant E2-ubiquitin adduct (29.5 kDa) . A similar autoubiquitination product with native E2-C is seen with a mixture of natural E2-C and E2-A (Fig. 5B, lane 2) . In this case, some formation of high molecular weight ubiquitin-protein conjugates is seen. This is presumably due to the action of E2-A, which had been found previously to coincide with a nonspecific ubiquitination activity (5). It thus seems that at least by the criterion of the lack of its action with a nonspecific E3, the recombinant clam E2-C is selective for the cyclin ubiquitination system, as indicated by previous studies on the partially purified natural enzyme (5).
We thus conclude that the cDNA clone described here encodes the cyclin-selective E2-C that is responsible for the cell cycle stage-specific ubiquitination and destruction of mitotic cyclins A and B.
DISCUSSION
The selective ubiquitination and subsequent proteolysis of cyclins A and B near the end of mitosis is carried out by two components. First described in clam oocytes, these are a cyclin-selective ubiquitin carrier protein activity, E2-C, and a cyclin-selective ubiquitin ligase activity, E3-C, which catalyzes transfer of ubiquitin from E2-C to the target protein cyclin. Recent work has revealed that the ligase activity is part of an -22S complex, called the cyclosome in clams (6) and the APC in frogs, which contains homologs of at least two yeast cdc genes (9) , but neither the identity of the ligase itself nor the basis of its substrate specificity is known. By contrast, several candidates have been suggested as cyclin-selective UBCs. In the budding yeast S. cerevisiae, repression of UBC9 synthesis blocks the cell cycle in either late G2 or early M, and both the S phase cyclin CLB5 and the mitotic cyclin CLB2 fail to be degraded in these cells (18 (9) . UBC4 involvement was somewhat surprising because of the lack of any demonstrable effect on cyclin destruction or cell cycle progression in yeast, where it clearly plays obvious roles in the turnover of abnormal proteins and the destruction of some rapidly turning-over normal proteins (13). These features are in striking contrast to those of UBC3 (cdc34) in which mutations cause a discrete G1 arrest (16) , most likely by their requirement in the pathway leading to proteolysis of the cyclin-dependent kinase inhibitor p40sicl (17) . Furthermore, a second UBC activity that also supported cyclin ubiquitination in frog egg extracts was noted (9) .
In view of these disparate results, we took advantage of previous work in which we identified and partially purified a discrete UBC activity that was required for ubiquitination of mitotic cyclins in extracts of clam oocytes (5) . This activity, called E2-C, was distinguished as the major cyclin-specific UBC activity on the basis of (i) its ability to ubiquitinate both Proc. Natl. Acad. Sci. USA 93 (1996) cyclin A and B, but not most other cellular proteins, (ii) the absolute dependence of this reaction on the presence of an intact unscrambled destruction box, and (iii) the corequirement for a cyclin-specific ubiquitin ligase activity, E3-C, that resides in an -22S particle, the cyclosome (5, 6) . With purified E2-C in hand, it was possible to clone the corresponding cDNA from clam oocytes, confirm that the recombinant protein encoded by this cDNA did in fact exhibit the same properties as native endogenous E2-C in cyclin ubiquitination assays, and determine the identity of E2-C. By contrast, UBC4 stimulated cyclin ubiquitination only at very high concentrations, suggesting a low-affinity ubiquitin transfer from a nonspecific E2. These results clearly establish that E2-C is the specific UBC required for ubiquitination of the mitotic cyclins.
Comparisons of the sequence of E2-C with those of other cloned UBCs clearly indicates that it is a novel UBC. Recently, we have cloned a human E2-C (F. Townsley, S. Beck, A.H., and J.V.R., unpublished data). UBC 
